Overexpression of toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice

被引:82
作者
Bihl, F
Salez, L
Beaubier, M
Torres, D
Larivière, L
Laroche, L
Benedetto, A
Martel, D
Lapointe, JM
Ryffel, B
Malo, D
机构
[1] Montreal Gen Hosp, Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
[4] CNRS, F-45071 Orleans, France
[5] Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA
基金
加拿大健康研究院;
关键词
D O I
10.4049/jimmunol.170.12.6141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors are transmembrane proteins that are involved in the innate immune recognition of microbial constituents. Among them, Toll-like receptor 4 (Tlr4) is a crucial signal transducer for LPS, the major component of Gram-negative bacteria outer cell membrane. The contribution of Tlr4 to the host response to LPS and to infection with virulent Salmonella typhimurium was studied in four transgenic (Tg) strains including three overexpressing Tlr4. There was a good correlation between the level of Tlr4 mRNA expression and the sensitivity to LPS both in vitro and in vivo: Tg mice possessing the highest number of Tlr4 copies respond the most to LPS. Overexpression of Tlr4 by itself appears to have a survival advantage in Tg mice early during infection: animals possessing more than two copies of the gene survived longer and in a greater percentage to Salmonella infection. The beneficial effect of Tlr4 overexpression is greatly enhanced when the mice present a wild-type allele at natural resistance-associated macrophage protein 1, another critical innate immune gene involved in resistance to infection with Salmonella. Tlr4 and natural resistance-associated macrophage protein 1 exhibit functional epistatic interaction to improve the capacity of the host to control bacterial replication. However, this early improvement in disease resistance is not conducted later during infection, because mice overexpressing Tlr4 developed an excessive inflammatory response detrimental to the host.
引用
收藏
页码:6141 / 6150
页数:10
相关论文
共 72 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages [J].
Akashi, S ;
Shimazu, R ;
Ogata, H ;
Nagai, Y ;
Takeda, K ;
Kimoto, M ;
Miyake, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3471-3475
[3]  
[Anonymous], 1994, MANIPULATING MOUSE E
[4]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[5]  
BARRERA LF, 1994, IMMUNOLOGY, V82, P457
[6]   I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M-bovis BCG [J].
Barrera, LF ;
Kramnik, I ;
Skamene, E ;
Radzioch, D .
MOLECULAR IMMUNOLOGY, 1997, 34 (04) :343-355
[7]   YAC transgenesis: a study of conditions to protect YAC DNA from breakage and a protocol for transfection [J].
Bauchwitz, R ;
Costantini, F .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1401 (01) :21-37
[8]   LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4 [J].
Bihl, F ;
Larivière, L ;
Qureshi, ST ;
Flaherty, L ;
Malo, D .
GENES AND IMMUNITY, 2001, 2 (01) :56-59
[9]   CYTOKINE-MEDIATED ACTIVATION OF MACROPHAGES FROM MYCOBACTERIUM-BOVIS BCG-RESISTANT AND BCG-SUSCEPTIBLE MICE - DIFFERENTIAL-EFFECTS OF CORTICOSTERONE ON ANTIMYCOBACTERIAL ACTIVITY AND EXPRESSION OF THE BCG GENE (CANDIDATE NRAMP) [J].
BROWN, DH ;
LAFUSE, W ;
ZWILLING, BS .
INFECTION AND IMMUNITY, 1995, 63 (08) :2983-2988
[10]   Structural and functional analyses of bacterial lipopolysaccharides [J].
Caroff, M ;
Karibian, D ;
Cavaillon, JM ;
Haeffner-Cavaillon, N .
MICROBES AND INFECTION, 2002, 4 (09) :915-926